Three independent studies have shown that an α-synuclein assay technology detected early Parkinson's with high levels of sensitivity and specificity.
The funding will be used to support the the newly established ME/CFS Collaborative Research Center at Stanford University.
The trial aims to demonstrate the utility of Biocept's Target Selector PD-L1 assay in patients diagnosed with non-small cell lung cancer.
Mass spectrometry cerebral spinal fluid assay can help differentiate between Alzheimer's and other forms of dementia, Quest says
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
The developers said that their multivariant analysis does a better job than using APOE E4 alone at identifying those at greatest risk of developing Alzheimer's.